Multi-Site Trial of Tirzepatide for Smoking Cessation
Multi-Site Trial of Tirzepatide for Smoking Cessation
Recruiting · NCT07602699 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-Site Trial of Tirzepatide for Smoking Cessation | Chemically-Induced Disorders, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-07-17 | NCT07602699 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Drug Abuse (NIDA) | 549 |
| University of Southern California | 216 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Keck School of Medicine, University of Southern California | Los Angeles | United States | 3 |
| University of Chicago Pritzker School of Medicine | Chicago | United States | 2 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| Yale University School of Medicine | New Haven | United States | 44 |